Emergencies in the Cancer Patient 2024

Oncologic emergencies have rapidly evolved in medicine over the last 10-15 years. It continues to develop in parallel with evolving cancer treatments and interventions. In addition to treating complications related to standard/traditional chemotherapies, the development of numerous new cancer treatment modalities presents a whole new field of patient complaints that are just now starting to be seen in emergency departments across the country. With very few dedicated cancer hospital emergency rooms, patients presenting with cancer emergencies are often inappropriately triaged, diagnosed, undertreated, or often simply referred back to their respective oncologists without resolution of their emergent issues.

This two-day, live hybrid conference will bring together specialists from across all areas of the cancer treatment spectrum in order to update and enhance the ability of emergency department providers and staff on how to prepare for the common and not-so-common emergency scenarios with which a cancer patient could present. Each session will include didactic lectures followed by a live Q&A session.

This conference offers participants the choice of attending either in person or virtually and is intended for physicians, nurse practitioners, physician assistants, and registered nurses involved in the treatment and management of patients with active malignancies/cancers who present with acute complaints in an emergent room setting.

1. Identify and recognize the most common presenting complaints of cancer patients in emergency rooms.
2. Discuss current and developing cancer therapeutics with respect to their side-effects and complications.
3. Recognize the current limitations and challenges that remain in efficiently addressing cancer patient emergencies.

This conference offers participants the choice of attending either in person or virtually. In-person registrants will be provided continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the conference if you have any special dietary requests or require any specific accommodations for joining us onsite.

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

Registration Rates

Physicians (MDs, PhDs, and DOs): $550
Advanced Practice Providers: $450
Nursing and Other Healthcare Professionals: $400
Residents, Fellows, and Students: $200
Industry Professionals*: $965
MSK Employees: Complimentary

For details on our cancellation terms, please review our Cancellation Policy.

*An “industry professional” is defined as any individual, regardless of their profession type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. View our Registration Policy for Industry Professionals for more information.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Memorial Sloan Kettering Cancer Center–Nursing Professional Development / Continuing Education is accredited with distinction as a provider of nursing continuing professional development (NCPD) by the American Nurses Credentialing Center’s Commission on Accreditation.

15.25 contact hours will be awarded to participants who attend the program in its entirety and complete a program evaluation. Partial credit not awarded.

Hotel Accommodations

We look forward to welcoming you to Memorial Sloan Kettering for this program. If you’ll be traveling to New York City from out of town, we recommend that you plan your overnight stays as soon as possible. To make the planning a little easier, Memorial Sloan Kettering has negotiated special rates and amenities at select hotels in Manhattan. To view the list of select hotels and additional details on each, please visit: msk.org/accommodations

Parking Information

Street parking in Manhattan is extremely limited, so you may find it more convenient to park in Memorial Sloan Kettering’s garage or in a commercial garage. For a list of parking resources around MSK, click here. Please note that MSK CME does not offer parking validation for course attendees.

MSK Conference Director

George K. Wang, MD, PhD
Associate Attending, Emergency Care Service,
Department of Medicine

MSK Conference Moderator 

Thomas John, MD
Assistant Attending, Emergency Care Service,
Department of Medicine

Invited Faculty 

Tim Cooksley, MD, FRCP
The Christie NHS Foundation Trust
Manchester, UK 

MSK Faculty 

Mark H. Bilsky, MD
William E. Snee Chair;
Vice Chairman of Clinical Affairs, Neurosurgery;
Chief, Multi-Disciplinary Spine Tumor Service; 
Attending, Department of Neurosurgery

Adrienne A. Boire, MD, PhD
Geoffrey Beene Junior Faculty Chair;
Associate Attending, 
Department of Neurology

Sanjay Chawla, MD, FCCP, FACP, FCCM
Attending, Critical Care Medicine Service, 
Department of Anesthesiology-Critical Care

Linda Chen, MD
Assistant Attending, 
Department of Radiation Oncology

Azeez Farooki, MD
Attending, Endocrinology Service,
Department of Medicine

Allison Gordon, MD
Assistant Attending, Dermatology Service,
Department of Medicine

Jeffrey S. Groeger, MD
Attending, Emergency Care Service,
Department of Medicine

Avi Leader, MD
Assistant Attending, Hematology Service,
Department of Medicine

Robert P. Lee, MD, FCCP, DAABIP
Section Head, Interventional Pulmonology;
Program Director, Interventional Pulmonology Fellowship;
Associate Attending, Pulmonary Service,
Department of Medicine

Aron Legler, MD, FASA
Assistant Attending, Anesthesiology Service,
Department of Anesthesiology-Critical Care

Peter A. Mead, MD
Assistant Attending, Infectious Diseases Service,
Department of Medicine

Mark Melrose, DO, FACEP
Associate Attending, Emergency Care Service,
Department of Medicine

Gilles Salles, MD, PhD
Chief, Lymphoma Service,
Steven A. Greenberg Chair,
Department of Medicine

Reggie Saldivar, MD, FCCP, FACP, FCCM
Associate Attending, Supportive Care,
Department of Medicine

Fernando C. Santini, MD
Assistant Attending, Thoracic Oncology Service,
Department of Medicine

Michael Scordo, MD
Assistant Attending, Bone Marrow Transplant Service,
Department of Medicine

Valeria Silva Merea, MD
Director, Speech and Hearing Center;
Assistant Attending, Head and Neck Service,
Department of Surgery

Iris H. Wei, MD, FACS
Assistant Attending, Colorectal Service,
Department of Surgery

Amy Xu, MD, PhD
Co-Director, Inpatient Radiation Oncology Consult (IROC) Service;
Assistant Attending, 
Department of Radiation Oncology

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Memorial Sloan Kettering Cancer Center gratefully acknowledges the following organization for providing a medical education grant this live activity:

Janssen Scientific Affairs, LLC

Memorial Sloan Kettering Cancer Center is pleased to announce that the following company will be exhibiting during this conference:

Agios Pharmaceuticals